logo

DRMA

Dermata Therapeutics·NASDAQ
--
--(--)
--
--(--)

DRMA fundamentals

Dermata Therapeutics (DRMA) released its earnings on Aug 13, 2025: revenue was -- (YoY --), beat estimates; EPS was -1.66 (YoY +96.03%), beat estimates.
Revenue / YoY
--
--
EPS / YoY
-1.66
+96.03%
Report date
Aug 13, 2025
EPS
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-1680-744-792-576-480-336-340.5-94.5-81-67.5-4.7-41.8-20.4-13.4-4.5-1.66
Forecast
-1680-1332-1008-960-768-528-480-397.5-138-94.5-117-54-37.9-26.4-15-4.5-2.9
Surprise
0.00%
0.00%
+26.19%
+17.50%
+25.00%
+9.09%
+30.00%
+14.34%
+31.52%
+14.29%
+42.31%
+91.30%
-10.29%
+22.73%
+10.67%
0.00%
+42.76%
Revenue
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
----------------------------------
Forecast
----------------------------------
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Earnings Call